Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T08:31:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor version update and does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-03-07T19:32:17.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-14T04:47:28.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated: added v3.4.1 and removed v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-06T20:41:05.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Show glossary and Hide glossary controls and updated revision metadata to Revision: v3.4.0 and Last Update Submitted that Met QC Criteria, replacing the previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-23T18:19:03.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page's revision history.
    Difference
    0.0%
    Check dated 2026-01-16T12:10:38.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.